{
    "2019-11-08": [
        [
            {
                "time": "",
                "original_text": "贝达药业收关注函：要求说明汪炜提名其为公司独立董事候选人的理由 关注函",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "关注函",
                        "独立董事",
                        "汪炜"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "近5日机构密集调研95家公司 17只潜力股月内吸金均超千万元",
                "features": {
                    "keywords": [
                        "机构调研",
                        "潜力股",
                        "吸金",
                        "95家公司",
                        "17只股票"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}